These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38546696)

  • 1. Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Garderet L; Gras L; Koster L; De Wreede L; Montserrat R; Vincent L; Fenk R; Karunanithi K; Deeren D; Kaufmann M; Kuball J; Ozdogu H; Cascon MJP; Passweg J; Rye A; Salmenniemi U; Snowden J; Hansen CT; Leleu X; Gastaud L; Sokolowska JD; Raj K; Beksac M; Schönland S; Hayden P; McLornan D
    Haematologica; 2024 Aug; 109(8):2619-2627. PubMed ID: 38546696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system.
    Muchtar E; Gertz MA; Mwangi R; Hassan H; Dispenzieri A; Leung N; Buadi FK; Dingli D; Staron A; Sanchorawala V
    Am J Hematol; 2024 Nov; 99(11):2118-2126. PubMed ID: 39207186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
    Mounier N; Canals C; Gisselbrecht C; Cornelissen J; Foa R; Conde E; Maertens J; Attal M; Rambaldi A; Crawley C; Luan JJ; Brune M; Wittnebel S; Cook G; van Imhoff GW; Pfreundschuh M; Sureda A;
    Biol Blood Marrow Transplant; 2012 May; 18(5):788-93. PubMed ID: 22005647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Kyriakou C; Canals C; Sibon D; Cahn JY; Kazmi M; Arcese W; Kolbe K; Gorin NC; Thomson K; Milpied N; Niederwieser D; Indrák K; Corradini P; Sureda A; Schmitz N
    J Clin Oncol; 2010 May; 28(13):2227-32. PubMed ID: 20368570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
    Garderet L; Iacobelli S; Koster L; Goldschmidt H; Johansson JE; Bourhis JH; Krejci M; Leleu X; Potter M; Blaise D; Koenecke C; Peschel C; Radocha J; Metzner B; Lenain P; Schäfer-Eckart K; Pohlreich D; Grasso M; Caillot D; Einsele H; Ladetto M; Schönland S; Kröger N
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1372-1378. PubMed ID: 29408334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
    Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
    Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation for systemic lupus erythematosus.
    Jayne D; Passweg J; Marmont A; Farge D; Zhao X; Arnold R; Hiepe F; Lisukov I; Musso M; Ou-Yang J; Marsh J; Wulffraat N; Besalduch J; Bingham SJ; Emery P; Brune M; Fassas A; Faulkner L; Ferster A; Fiehn C; Fouillard L; Geromin A; Greinix H; Rabusin M; Saccardi R; Schneider P; Zintl F; Gratwohl A; Tyndall A; ;
    Lupus; 2004; 13(3):168-76. PubMed ID: 15119545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
    Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
    Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
    Cohen YI; Lebel E; Zimran E; Shaulov A; Stepensky P; Grisariu S; Avni B
    Transplant Cell Ther; 2023 Aug; 29(8):505.e1-505.e8. PubMed ID: 37160229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
    Christopeit M; Labopin M; Gorin NC; Saraceni F; Passweg J; Forcade E; Maertens J; Van Lint MT; Bosi A; Niederwieser D; Ehninger G; Polge E; Mohty M; Nagler A
    Am J Hematol; 2018 Dec; 93(12):1532-1542. PubMed ID: 30218444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
    Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
    Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency.
    Cordes S; Gertz MA; Buadi FK; Lin Y; Lacy MQ; Kapoor P; Kumar SK; McCurdy A; Dispenzieri A; Dingli D; Hayman SR; Hogan WJ; Pruthi RK
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):101-8. PubMed ID: 26218969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
    Sharpley FA; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Whelan CJ; Fontana M; Martinez-Naharro A; Quarta C; Hawkins PN; Wechalekar AD
    Br J Haematol; 2019 Dec; 187(5):642-652. PubMed ID: 31410841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation.
    Fox CP; Boumendil A; Schmitz N; Finel H; Luan JJ; Sucak G; Blaise D; Finke J; Pflüger KH; Veelken H; Gorin NC; Poiré X; Ganser A; Dreger P; Sureda A
    Leuk Lymphoma; 2015; 56(12):3295-300. PubMed ID: 25899403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
    Tun AM; Maliske S; Wang Y; Inwards DJ; Habermann TM; Micallef I; Porrata L; Paludo J; Bisneto JV; Rosenthal A; Kharfan-Dabaja MA; Ansell SM; Nowakowski GS; Farooq U; Johnston PB
    Transplant Cell Ther; 2022 Sep; 28(9):610-617. PubMed ID: 35752441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.
    Kawajiri-Manako C; Sakaida E; Ohwada C; Miyamoto T; Azuma T; Taguchi J; Mori T; Hasegawa Y; Kondo T; Yujiri T; Yoshimitsu M; Imada K; Kurahashi S; Kahata K; Ichinohe T; Hirokawa M; Atsuta Y; Nakaseko C
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1180-1186. PubMed ID: 29409882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.